Navigation Links
CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
Date:9/19/2007

KIRKLAND, Wash., Sept. 19 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (the "Company") (OTC Bulletin Board: CCYG) has formed a new Device Division in order to develop, manufacture and market its patented line of stem cell cultivation and replication devices.

CellCyte Genetics is developing stem cell enabling therapeutic products designed to allow more efficient delivery and significantly increased retention of adult stem cells to diseased organs, such as the heart.

Along with its planned human trials for its therapeutics, CellCyte Genetics intends to develop a new stem cell cultivation device or "bioreactor" unit for which CellCyte Genetics owns the worldwide patent and rights. The Company plans to market the device for applications that will require cells to be grown under regulated oxygen concentrations, e.g. the replication of stem cells and the culture of pancreatic islet cells prior to transplantation into diabetic patients.

Dr. Ron Berninger, Chief Scientific Officer of CellCyte Genetics explains, "CellCyte's patented biological cell maintenance system has the unique ability to incubate cultured cells with a very efficient and regulatable oxygen supply, making it an ideal choice for culturing cells that are otherwise difficult to keep alive or to expand. Inside the bioreactor, the cells can also form a 3-dimensional network, which is what most cell types do in major organs of the body."

A key element of this bioreactor is the capability to supply oxygen (by bundles of oxygen fibers) to the cells throughout the entire space in which cells are growing. Stem cells appear to be sensitive to oxygen levels and can be induced to replicate or differentiate in part by controlling the oxygen level.

Using CellCyte's product, scientists, researchers and clinicians should be able to dramatically increase the number of stem cells available for research and potentially for use in stem cell therapies. Management believes that th
'/>"/>

SOURCE CellCyte Genetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related biology technology :

1. Wisconsin court affirms damages in Innogenetics, Abbott patent case
2. Third Wave licenses Innogenetics tech to settle lawsuit
3. Symposium examines the effect of race on genetics and disease
4. Metavante Corp. will continue M&A activity
5. Lucigen Corp. enters global licensing agreement
6. CIO Leadership Series: Jane Durment, Marcus Corp.
7. Brady Corp. acquires Korean counterpart
8. Brady Corp. raises $137 million in public offering
9. Symphony Corp. and CareEvolution to partner
10. RedPrairie Corp. introduces new supply chain software
11. California investors acquire RedPrairie Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...tCall/ -- Cell Therapeutics, Inc. ("CTI",or the "...hat a single,institutional investor shall purchas...le Senior Notes due 2011 (the "Notes"), with a con...ew Notes would have a $32.65 million initial princ...ntitling the holder, upon any conversion of,the N...
(Date:12/4/2008)...rstCall/ -- Favrille, Inc.,(OTC Bulletin Board: F...lth,information company focused on secure Web-bas...(PHRs), announced today that two significant condi...e merger agreement have been met. , (Logo: ...521LOGO ) , "We are pleased to announce tha...
(Date:12/4/2008)...wswire/ -- Researchers are taking a closer look at...y as studies continue to demonstrate that inhibiti...reports Genetic Engineering & Biotechnology N...s, cell growth, differentiation, and survival. In ...which plays a key role in cancer, according to the...
(Date:12/4/2008)...arch of potential vaccine for low-resource countri... 4 The biotech company Lentigen Co...tion PATH announced today a partnership to acceler... will initially invest $3 million over 27 months a...f a H5N1 virus-like particle (VLP) prototype pande...
Breaking Biology Technology:Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes 3Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 2Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 3Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 4Favrille and MyMedicalRecords.com, Inc. Obtain Shareholder Approval to Move Forward With Merger 5GEN Reports Growing Focus on PI3-Kinase Pathway in Cancer Research 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 3
... a new device that holds 33% more data than the pr...er the June 2003 launch of the 1.5 GB Cornice Stor...he 2.0-gigabyte Cornice Storage Element. These st...rtable devices, and other applications that demand... a small space. , ,The 2.0-gigabyte Storage Eleme...
...s start with the good in Midwest biotech in 2003. ...nce of the publicly traded Midwest biotech compani...ex, which evaluates the top 20 biotech stocks of t...ar performance of the Nasdaq and Amex Biotech indi...ticked up even more in the last trading days of th...
...API was named to the top five in the "specialty ni...dance by KLAS , a provider of healthcare informat...API solutions received top overall score for all t...rcent higher than their 2002 Best In KLAS Performa...rmation technology (HIT) industry with unbiased fa...
...Need a new look on life? Ingineos new Eyetop Cen...entras are multimedia sunglasses with a built-in 1...t make watching TV while mowing the lawn or riding...miniaturized screen in the lower center of one len...staying in touch with their surroundings. Earplugs...
Other Biology Technology:With Larger Storage Capacity Comes Smaller Devices 2The Good, Bad, Ugly of Midwest Biotech in 2003 2The Good, Bad, Ugly of Midwest Biotech in 2003 3API Receives Top 5 Recognition in "Best In KLAS" Awards 2
(Date:12/3/2008)...ecember 14-17, 2008 at the University,s Sede Boqer...of BGU,s Jacob Blaustein Institutes for Desert Res...ence are the United Nations Educational, Scientifi...istry for Foreign Affairs, Jewish National Fund, t...al leader in smart water solutions for agriculture...
(Date:12/3/2008)...ed as safe for pregnancy - other asthma drugs have...sually keep using the same asthma drugs they were ...are the best studied and can be regarded as safe. ...sary however. According to the German Institute fo...ore data from trials could reassure women who worr...
(Date:12/3/2008)...omises to enable cheap, lifesaving new drugs to tr...aria, and to create innovative biofuels that can h...ience and its applications are raising questions: ...scientists purposely changing the definition of wh...ntentionally equipping terrorists with frightening...
(Date:12/2/2008)...ing is easier than ever, but the amount of data to...er program now shows that genome sequence analysis...searchers find hidden relationships in massive amo... of Energy,s Pacific Northwest National Laboratory...percomputing ,08 High Performance Computing Analyt...
Breaking Biology News(10 mins):Ben-Gurion University of the Negev to host 2Pregnant women with asthma can be more confident about some medicines 2Synthetic biology: Is ethics a showstopper? 2PNNL researchers earn top honors at Supercomputing conference 2PNNL researchers earn top honors at Supercomputing conference 3The Healing Power of Green 4894 1The Healing Power of Green 4894 2The Healing Power of Green 4894 3SuperGen Reports 2007 Third Quarter Financial Results 4890 1SuperGen Reports 2007 Third Quarter Financial Results 4890 2SuperGen Reports 2007 Third Quarter Financial Results 4890 3SuperGen Reports 2007 Third Quarter Financial Results 4890 4SuperGen Reports 2007 Third Quarter Financial Results 4890 5SuperGen Reports 2007 Third Quarter Financial Results 4890 6SuperGen Reports 2007 Third Quarter Financial Results 4890 7SuperGen Reports 2007 Third Quarter Financial Results 4890 8SuperGen Reports 2007 Third Quarter Financial Results 4890 9SuperGen Reports 2007 Third Quarter Financial Results 4890 10Nastech Announces Third Quarter 2007 Financial Results 1573 1Nastech Announces Third Quarter 2007 Financial Results 1573 2Nastech Announces Third Quarter 2007 Financial Results 1573 3Nastech Announces Third Quarter 2007 Financial Results 1573 4Nastech Announces Third Quarter 2007 Financial Results 1573 5Nastech Announces Third Quarter 2007 Financial Results 1573 6Smoking Does Not Worsen Breast Cancer 4886 1Smoking Does Not Worsen Breast Cancer 4886 2Smoking Does Not Worsen Breast Cancer 4886 3
.... Waste. Energy. This trio of problems is among...th of society. Water purification alone is becomi...singly reliance on contaminated sources, such as p...hese issues are closely interrelated," says Bruce ... Biotechnology in the Biodesign Institute at ASU. ...
...rs researchers have identified a gene ?and the mol...des an important clue to further understanding obe... fat metabolism. , The scientists found that the...ing enzyme. "Lipin activity may be an important p...n humans, treating conditions that range from obes...
...rchers here have cracked the site and the stages o...ne cells. , The researchers found that natural ki...nses against cancer and infections, mature from pr...also found that this happens in secondary lymphoid...discoveries made decades ago in animals and humans...
...alysis of H5N1 influenza samples in Southeast Asia...ed human disease are related but also that they be... Researchers from the Centers for Disease Control... International Conference on Emerging Infectious D...expansion, it is also undergoing genetic diversity...
Other Biology News:Earth Rx: A microbial biotechnology prescription for global environmental health 2Earth Rx: A microbial biotechnology prescription for global environmental health 3Rutgers researchers find fat gene 2Front-line immune cells mature in four stages, study shows 2Study outlines genetic differences between potential pandemic influenza strains 2
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (C6671) or contact customer s
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,371-6) or contact custom
BD BioCoat Collagen IV 150 mm Culture Dishes
Peptone from Sigma-Aldrich
Biology Products: